Blanket Purchase Agreement 36F79720D0083-36C25520A0037
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 awarded a single-award Blanket Purchase Agreement (BPA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, to provide cost-per-test clinical laboratory analyzers and associated products and services. The $939,392.25 BPA covers the supply of in-vitro diagnostic testing equipment, reagents, and accessories through February 2030. The original solicitation sought to...
- This Blanket Purchase Agreement (BPA) was awarded by the Air Education and Training Command, a defense agency, to Grifols Diagnostic Solutions Inc., a for-profit subsidiary of the global healthcare company Grifols. The $7,500,000 single-award BPA covers the provision of Procleix Reagents for Nucleic Acid Testing (NAT) for detecting Human Immunodeficiency Virus (HIV), Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and West Nile Virus (WNV). This specialized medical laboratory equipment and...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 1 (VISN 1) of the U.S. Department of Veterans Affairs (VA) to Werfen USA LLC, a for-profit manufacturer of in vitro diagnostic equipment, reagents, and services. The BPA, valued at up to $300,000.00, is for the provision of blood bank reagents under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, and Tests. The contract has a period of performance from September 15, 2023 through...
- Grifols Diagnostic Solutions Inc., a foreign-owned subsidiary of the global healthcare company Grifols, was awarded a Blanket Purchase Agreement (BPA) by Veterans Integrated Service Network 20 on November 6, 2023, with a ceiling value of $470,881.60 and an ultimate completion date of October 31, 2026. The contract, issued without set-aside designation, establishes a vehicle for the Portland Veterans Affairs Medical Center to procure automated gel testing equipment, reagents, and associated...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 15 (VISN 15) of the U.S. Department of Veterans Affairs (VA) to Werfen USA LLC, a Massachusetts-based manufacturer of in vitro diagnostic equipment, reagents, and services. The $417,068.20 contract is for the delivery of blood bank reagents and was awarded under the General Services Administration's (GSA) Invitro Diagnostics, Reagents, Test (FSS-65-VII) schedule contract. The contract has a period of...
- Grifols Diagnostic Solutions Inc. was awarded a blanket purchase agreement (BPA) under the Critical Analyzers, Laboratory Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20. The BPA has a potential value of $447,337.52 and period of performance through April 30, 2028. Under the BPA, Grifols will provide blood bank testing services to support healthcare programs for veterans in the Oakland, California region. A...
- This Blanket Purchase Agreement (BPA) is a single-award federal contract Indefinite Delivery Vehicle (IDV) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 to Alba Bioscience, Inc., a foreign-owned for-profit organization. The contract, valued at $109,420.35, is for the delivery of red blood cell reagents and other blood banking products to support VA medical facilities across the country. The contract was awarded under the General Services Administration...
- This federal contract Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Werfen USA LLC, a Bedford, Massachusetts-based manufacturer and supplier of in vitro diagnostic (IVD) equipment, reagents, and services for clinical laboratories and point-of-care medical settings. The single-award BPA has a ceiling value of $229,299.85 and a period of performance through September 30, 2030. The contract vehicle is primarily used to procure blood bank reagents, with...
- This Blanket Purchase Agreement (BPA) is a single-award contract between the U.S. Department of Veterans Affairs (VA) and Alba Bioscience, Inc., a foreign-owned for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to federal agencies. The BPA, valued at $199,671.75, is under the GSA Schedule 65-VII for in vitro diagnostics, reagents, and tests, and has a performance period through May 31, 2030. It...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 to Werfen USA LLC, a manufacturer and supplier of in vitro diagnostic equipment, reagents, and services. The contract, valued at $1,428,493.95, is for the delivery of laboratory reagents and supplies over a period ending June 30, 2025. The contract utilizes the Multiple Award Schedule (MAS) contracting vehicle and has a firm fixed price pricing structure. Werfen...
- Invitro Diagnostics, Reagents, Test (FSS-65-VII)Master GSA Schedule
- 36F79720D0083Federal Supply Schedule
- 36F79720D0083-36C25520A0037Blanket Purchase Agreement
- 3Federal Contract Awards
This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) to Grifols Diagnostic Solutions Inc., a foreign-owned for-profit company, for the supply of blood bank reagents. The contract, valued at up to $36,593.10, has an ultimate completion date of May 31, 2022 and was awarded on June 1, 2020. The BPA was established under the VA's GSA Schedule 65-VII for In Vitro Diagnostics, Reagents, Test Kits & Test Sets. Grifols, a global healthcare company, has received over $8 million in federal awards as a prime contractor, providing medical laboratory equipment and supplies to agencies like the VA, Defense Health Agency, and Department of the Air Force. This contract supports blood screening, donor testing, and diagnostics for infectious diseases at VA medical centers across the country. No set-aside designations were used for these awards to Grifols.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $0 | 5/3/21 | |
| Not listed | Not listed | $0 | 5/21/20 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C25520A0037-36C25522N0312 | Grifols Diagnostic Solutions Inc. | $0 | 6/1/22 | 5/31/23 | 5/1/25 | |
BPA Call 36C25520A0037-36C25521N0252 | Grifols Diagnostic Solutions Inc. | $0 | 6/1/21 | 5/31/22 | 5/1/25 | |
BPA Call 36C25520A0037-36C25520N0289 | Grifols Diagnostic Solutions Inc. | $33.6k | 6/1/20 | 5/31/21 | 6/1/20 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
2835--VISN 15 Blood Bank Liquid Reagents Amended Sources Sought | 36C25520Q0275 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Solicitation 3/3 | 4/4/20, 11:06 AM | |
2835--VISN 15 Blood Bank Liquid Reagents Amended Sources Sought | 36C25520Q0275 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Special Notice 2/3 | 3/18/20, 1:47 PM | |
2835--Blood Bank Reagents | 36C25520Q0275 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 15 | Pre-Solicitation 1/3 | 3/16/20, 1:50 PM |